A recent ethics filing has disclosed thousands of stock trades tied to former president Trump, sparking concerns over potential conflicts of interest. The trades involve US corporate securities, including shares of specific companies such as Eli Lilly, and have raised eyebrows due to their timing and potential connection to Trump's policies. The nature and implications of these trades are unclear, with some outlets suggesting they may indicate insider trading or unethical behavior, while others simply report on the disclosure of the trades themselves.